APO Research
Talk to an analyst

APO RESEARCH · REPORT

Decentralized Clinical Trial Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Decentralized Clinical Trial Software Market Outlook and Growth Opportunities 2026

2 May 2026198 pages

Choose your research edition.

Industry ResearchDecentralized Clinical Trial Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Decentralized Clinical Trial Software Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Decentralized Clinical Trial Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decentralized Clinical Trial Software Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Decentralized Clinical Trial Software Market Analysis and Forecast 2026-2032236 pages · $4,950 USD

Market perspective

The global Decentralized Clinical Trial Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Decentralized Clinical Trial Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Decentralized Clinical Trial Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Decentralized Clinical Trial Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Decentralized Clinical Trial Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Decentralized Clinical Trial Software market include Medrio, Medable, TCS, Castor EDC, THREAD, ObvioHealth, Power, Veeva and SAHMRI, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Decentralized Clinical Trial Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Decentralized Clinical Trial Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Decentralized Clinical Trial Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Decentralized Clinical Trial Software market.

Decentralized Clinical Trial Software Segment by Company

Medrio

Medable

TCS

Castor EDC

THREAD

ObvioHealth

Power

Veeva

SAHMRI

IMI CARE

DNDi

Clario

Castor

Curebase

Infiuss

AGILE

OpenClinica

ClinCapture

DFdiscover

ClinPlus CTMS

Dacima Clinical Suite

Smartsheet

Snappii

RealTime-CTMS

Decentralized Clinical Trial Software Segment by Type

Web-based

Cloud-based

Decentralized Clinical Trial Software Segment by Application

Medical Device & Diagnostics

Biotech & Pharma

Contract Research Organizations

Academic Research

Others

Decentralized Clinical Trial Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Decentralized Clinical Trial Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Decentralized Clinical Trial Software key companies, revenue, market share, and recent developments.

3. To split the Decentralized Clinical Trial Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Decentralized Clinical Trial Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Decentralized Clinical Trial Software significant trends, drivers, influence factors in global and regions.

6. To analyze Decentralized Clinical Trial Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decentralized Clinical Trial Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decentralized Clinical Trial Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decentralized Clinical Trial Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Decentralized Clinical Trial Software industry.

Chapter 3: Detailed analysis of Decentralized Clinical Trial Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Decentralized Clinical Trial Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Decentralized Clinical Trial Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Decentralized Clinical Trial Software Industry Trends Table 2. Decentralized Clinical Trial Software Industry Drivers Table 3. Decentralized Clinical Trial Software Industry Opportunities and Challenges Table 4. Decentralized Clinical Trial Software Industry Restraints Table 5. Global Decentralized Clinical Trial Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Decentralized Clinical Trial Software Revenue Share by Company (2021-2026) Table 7. Global Decentralized Clinical Trial Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Decentralized Clinical Trial Software Key Company Manufacturing Base & Headquarters Table 9. Global Decentralized Clinical Trial Software Company, Product Type & Application Table 10. Global Decentralized Clinical Trial Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Decentralized Clinical Trial Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Web-based Table 15. Significant Companies of Cloud-based Table 16. Global Decentralized Clinical Trial Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Decentralized Clinical Trial Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Decentralized Clinical Trial Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Decentralized Clinical Trial Software Sales Value Share by Type (2021-2026) Table 20. Global Decentralized Clinical Trial Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Device & Diagnostics Table 22. Significant Companies of Biotech & Pharma Table 23. Significant Companies of Contract Research Organizations Table 24. Significant Companies of Academic Research Table 25. Significant Companies of Others Table 26. Global Decentralized Clinical Trial Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Decentralized Clinical Trial Software Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Decentralized Clinical Trial Software Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Decentralized Clinical Trial Software Sales Value Share by Application (2021-2026) Table 30. Global Decentralized Clinical Trial Software Sales Value Share by Application (2027-2032) Table 31. Global Decentralized Clinical Trial Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Decentralized Clinical Trial Software Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Decentralized Clinical Trial Software Sales Value Share by Region (2021-2026) Table 34. Global Decentralized Clinical Trial Software Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Decentralized Clinical Trial Software Sales Value Share by Region (2027-2032) Table 36. Global Decentralized Clinical Trial Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Decentralized Clinical Trial Software Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Decentralized Clinical Trial Software Sales Value Market Share by Country (2021-2026) Table 39. Global Decentralized Clinical Trial Software Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Decentralized Clinical Trial Software Sales Value Market Share by Country (2027-2032) Table 41. Medrio Company Information Table 42. Medrio Business Overview Table 43. Medrio Decentralized Clinical Trial Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Medrio Decentralized Clinical Trial Software Product Portfolio Table 45. Medrio Recent Development Table 46. Medable Company Information Table 47. Medable Business Overview Table 48. Medable Decentralized Clinical Trial Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Medable Decentralized Clinical Trial Software Product Portfolio Table 50. Medable Recent Development Table 51. TCS Company Information Table 52. TCS Business Overview Table 53. TCS Decentralized Clinical Trial Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. TCS Decentralized Clinical Trial Software Product Portfolio Table 55. TCS Recent Development Table 56. Castor EDC Company Information Table 57. Castor EDC Business Overview Table 58. Castor EDC Decentralized Clinical Trial Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Castor EDC Decentralized Clinical Trial Software Product Portfolio Table 60. Castor EDC Recent Development Table 61. THREAD Company Information Table 62. THREAD Business Overview Table 63. THREAD Decentralized Clinical Trial Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. THREAD Decentralized Clinical Trial Software Product Portfolio Table 65. THREAD Recent Development Table 66. ObvioHealth Company Information Table 67. ObvioHealth Business Overview Table 68. ObvioHealth Decentralized Clinical Trial Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. ObvioHealth Decentralized Clinical Trial Software Product Portfolio Table 70. ObvioHealth Recent Development Table 71. Power Company Information Table 72. Power Business Overview Table 73. Power Decentralized Clinical Trial Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Power Decentralized Clinical Trial Software Product Portfolio Table 75. Power Recent Development Table 76. Veeva Company Information Table 77. Veeva Business Overview Table 78. Veeva Decentralized Clinical Trial Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Veeva Decentralized Clinical Trial Software Product Portfolio Table 80. Veeva Recent Development Table 81. SAHMRI Company Information Table 82. SAHMRI Business Overview Table 83. SAHMRI Decentralized Clinical Trial Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. SAHMRI Decentralized Clinical Trial Software Product Portfolio Table 85. SAHMRI Recent Development Table 86. IMI CARE Company Information Table 87. IMI CARE Business Overview Table 88. IMI CARE Decentralized Clinical Trial Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. IMI CARE Decentralized Clinical Trial Software Product Portfolio Table 90. IMI CARE Recent Development Table 91. DNDi Company Information Table 92. DNDi Business Overview Table 93. DNDi Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. DNDi Decentralized Clinical Trial Software Product Portfolio Table 95. DNDi Recent Development Table 96. Clario Company Information Table 97. Clario Business Overview Table 98. Clario Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Clario Decentralized Clinical Trial Software Product Portfolio Table 100. Clario Recent Development Table 101. Castor Company Information Table 102. Castor Business Overview Table 103. Castor Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Castor Decentralized Clinical Trial Software Product Portfolio Table 105. Castor Recent Development Table 106. Curebase Company Information Table 107. Curebase Business Overview Table 108. Curebase Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Curebase Decentralized Clinical Trial Software Product Portfolio Table 110. Curebase Recent Development Table 111. Infiuss Company Information Table 112. Infiuss Business Overview Table 113. Infiuss Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Infiuss Decentralized Clinical Trial Software Product Portfolio Table 115. Infiuss Recent Development Table 116. AGILE Company Information Table 117. AGILE Business Overview Table 118. AGILE Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. AGILE Decentralized Clinical Trial Software Product Portfolio Table 120. AGILE Recent Development Table 121. OpenClinica Company Information Table 122. OpenClinica Business Overview Table 123. OpenClinica Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. OpenClinica Decentralized Clinical Trial Software Product Portfolio Table 125. OpenClinica Recent Development Table 126. ClinCapture Company Information Table 127. ClinCapture Business Overview Table 128. ClinCapture Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. ClinCapture Decentralized Clinical Trial Software Product Portfolio Table 130. ClinCapture Recent Development Table 131. DFdiscover Company Information Table 132. DFdiscover Business Overview Table 133. DFdiscover Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. DFdiscover Decentralized Clinical Trial Software Product Portfolio Table 135. DFdiscover Recent Development Table 136. ClinPlus CTMS Company Information Table 137. ClinPlus CTMS Business Overview Table 138. ClinPlus CTMS Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. ClinPlus CTMS Decentralized Clinical Trial Software Product Portfolio Table 140. ClinPlus CTMS Recent Development Table 141. Dacima Clinical Suite Company Information Table 142. Dacima Clinical Suite Business Overview Table 143. Dacima Clinical Suite Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Dacima Clinical Suite Decentralized Clinical Trial Software Product Portfolio Table 145. Dacima Clinical Suite Recent Development Table 146. Smartsheet Company Information Table 147. Smartsheet Business Overview Table 148. Smartsheet Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Smartsheet Decentralized Clinical Trial Software Product Portfolio Table 150. Smartsheet Recent Development Table 151. Snappii Company Information Table 152. Snappii Business Overview Table 153. Snappii Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Snappii Decentralized Clinical Trial Software Product Portfolio Table 155. Snappii Recent Development Table 156. RealTime-CTMS Company Information Table 157. RealTime-CTMS Business Overview Table 158. RealTime-CTMS Decentralized Clinical Trial Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. RealTime-CTMS Decentralized Clinical Trial Software Product Portfolio Table 160. RealTime-CTMS Recent Development Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Decentralized Clinical Trial Software Product Image Figure 2. Global Decentralized Clinical Trial Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Decentralized Clinical Trial Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Decentralized Clinical Trial Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Web-based Image Figure 8. Cloud-based Image Figure 9. Global Decentralized Clinical Trial Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Decentralized Clinical Trial Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Decentralized Clinical Trial Software Sales Value Share by Type (2021-2032) Figure 12. Medical Device & Diagnostics Image Figure 13. Biotech & Pharma Image Figure 14. Contract Research Organizations Image Figure 15. Academic Research Image Figure 16. Others Image Figure 17. Global Decentralized Clinical Trial Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Decentralized Clinical Trial Software Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Decentralized Clinical Trial Software Sales Value Share by Application (2021-2032) Figure 20. Global Decentralized Clinical Trial Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Decentralized Clinical Trial Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Decentralized Clinical Trial Software Sales Value (2021-2032) & (US$ Million) Figure 23. North America Decentralized Clinical Trial Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Decentralized Clinical Trial Software Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Decentralized Clinical Trial Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Decentralized Clinical Trial Software Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Decentralized Clinical Trial Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Decentralized Clinical Trial Software Sales Value (2021-2032) & (US$ Million) Figure 29. South America Decentralized Clinical Trial Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Decentralized Clinical Trial Software Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Decentralized Clinical Trial Software Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Web-based
  • Cloud-based
Applications
  • Medical Device & Diagnostics
  • Biotech & Pharma
  • Contract Research Organizations
  • Academic Research
  • Others
Companies covered
  • Medrio
  • Medable
  • TCS
  • Castor EDC
  • THREAD
  • ObvioHealth
  • Power
  • Veeva
  • SAHMRI
  • IMI CARE
  • DNDi
  • Clario
  • Castor
  • Curebase
  • Infiuss
  • AGILE
  • OpenClinica
  • ClinCapture
  • DFdiscover
  • ClinPlus CTMS
  • Dacima Clinical Suite
  • Smartsheet
  • Snappii
  • RealTime-CTMS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Decentralized Clinical Trial Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Decentralized Clinical Trial Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Decentralized Clinical Trial Software Market Dynamics
  1. 2.1 Decentralized Clinical Trial Software Industry Trends
  2. 2.2 Decentralized Clinical Trial Software Industry Drivers
  3. 2.3 Decentralized Clinical Trial Software Industry Opportunities and Challenges
  4. 2.4 Decentralized Clinical Trial Software Industry Restraints
3 Decentralized Clinical Trial Software Market by Company
  1. 3.1 Global Decentralized Clinical Trial Software Company Revenue Ranking in 2025
  2. 3.2 Global Decentralized Clinical Trial Software Revenue by Company (2021-2026)
  3. 3.3 Global Decentralized Clinical Trial Software Company Ranking (2024-2026)
  4. 3.4 Global Decentralized Clinical Trial Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Decentralized Clinical Trial Software Company Product Type and Application
  6. 3.6 Global Decentralized Clinical Trial Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Decentralized Clinical Trial Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Decentralized Clinical Trial Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Decentralized Clinical Trial Software Market by Type
  1. 4.1 Decentralized Clinical Trial Software Type Introduction
  2. 4.1.1 Web-based
  3. 4.1.2 Cloud-based
  4. 4.2 Global Decentralized Clinical Trial Software Sales Value by Type
  5. 4.2.1 Global Decentralized Clinical Trial Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Decentralized Clinical Trial Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Decentralized Clinical Trial Software Sales Value Share by Type (2021-2032)
5 Decentralized Clinical Trial Software Market by Application
  1. 5.1 Decentralized Clinical Trial Software Application Introduction
  2. 5.1.1 Medical Device & Diagnostics
  3. 5.1.2 Biotech & Pharma
  4. 5.1.3 Contract Research Organizations
  5. 5.1.4 Academic Research
  6. 5.1.5 Others
  7. 5.2 Global Decentralized Clinical Trial Software Sales Value by Application
  8. 5.2.1 Global Decentralized Clinical Trial Software Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Decentralized Clinical Trial Software Sales Value by Application (2021-2032)
  10. 5.2.3 Global Decentralized Clinical Trial Software Sales Value Share by Application (2021-2032)
6 Decentralized Clinical Trial Software Regional Value Analysis
  1. 6.1 Global Decentralized Clinical Trial Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Decentralized Clinical Trial Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Decentralized Clinical Trial Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Decentralized Clinical Trial Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Decentralized Clinical Trial Software Sales Value (2021-2032)
  7. 6.3.2 North America Decentralized Clinical Trial Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Decentralized Clinical Trial Software Sales Value (2021-2032)
  10. 6.4.2 Europe Decentralized Clinical Trial Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Decentralized Clinical Trial Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Decentralized Clinical Trial Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Decentralized Clinical Trial Software Sales Value (2021-2032)
  16. 6.6.2 South America Decentralized Clinical Trial Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Decentralized Clinical Trial Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Decentralized Clinical Trial Software Sales Value Share by Country, 2025 VS 2032
7 Decentralized Clinical Trial Software Country-level Value Analysis
  1. 7.1 Global Decentralized Clinical Trial Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Decentralized Clinical Trial Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Decentralized Clinical Trial Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Decentralized Clinical Trial Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Decentralized Clinical Trial Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Decentralized Clinical Trial Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Decentralized Clinical Trial Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medrio
  2. 8.1.1 Medrio Company Information
  3. 8.1.2 Medrio Business Overview
  4. 8.1.3 Medrio Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medrio Decentralized Clinical Trial Software Product Portfolio
  6. 8.1.5 Medrio Recent Developments
  7. 8.2 Medable
  8. 8.2.1 Medable Company Information
  9. 8.2.2 Medable Business Overview
  10. 8.2.3 Medable Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Medable Decentralized Clinical Trial Software Product Portfolio
  12. 8.2.5 Medable Recent Developments
  13. 8.3 TCS
  14. 8.3.1 TCS Company Information
  15. 8.3.2 TCS Business Overview
  16. 8.3.3 TCS Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TCS Decentralized Clinical Trial Software Product Portfolio
  18. 8.3.5 TCS Recent Developments
  19. 8.4 Castor EDC
  20. 8.4.1 Castor EDC Company Information
  21. 8.4.2 Castor EDC Business Overview
  22. 8.4.3 Castor EDC Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Castor EDC Decentralized Clinical Trial Software Product Portfolio
  24. 8.4.5 Castor EDC Recent Developments
  25. 8.5 THREAD
  26. 8.5.1 THREAD Company Information
  27. 8.5.2 THREAD Business Overview
  28. 8.5.3 THREAD Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 THREAD Decentralized Clinical Trial Software Product Portfolio
  30. 8.5.5 THREAD Recent Developments
  31. 8.6 ObvioHealth
  32. 8.6.1 ObvioHealth Company Information
  33. 8.6.2 ObvioHealth Business Overview
  34. 8.6.3 ObvioHealth Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ObvioHealth Decentralized Clinical Trial Software Product Portfolio
  36. 8.6.5 ObvioHealth Recent Developments
  37. 8.7 Power
  38. 8.7.1 Power Company Information
  39. 8.7.2 Power Business Overview
  40. 8.7.3 Power Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Power Decentralized Clinical Trial Software Product Portfolio
  42. 8.7.5 Power Recent Developments
  43. 8.8 Veeva
  44. 8.8.1 Veeva Company Information
  45. 8.8.2 Veeva Business Overview
  46. 8.8.3 Veeva Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Veeva Decentralized Clinical Trial Software Product Portfolio
  48. 8.8.5 Veeva Recent Developments
  49. 8.9 SAHMRI
  50. 8.9.1 SAHMRI Company Information
  51. 8.9.2 SAHMRI Business Overview
  52. 8.9.3 SAHMRI Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SAHMRI Decentralized Clinical Trial Software Product Portfolio
  54. 8.9.5 SAHMRI Recent Developments
  55. 8.10 IMI CARE
  56. 8.10.1 IMI CARE Company Information
  57. 8.10.2 IMI CARE Business Overview
  58. 8.10.3 IMI CARE Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 IMI CARE Decentralized Clinical Trial Software Product Portfolio
  60. 8.10.5 IMI CARE Recent Developments
  61. 8.11 DNDi
  62. 8.11.1 DNDi Company Information
  63. 8.11.2 DNDi Business Overview
  64. 8.11.3 DNDi Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 DNDi Decentralized Clinical Trial Software Product Portfolio
  66. 8.11.5 DNDi Recent Developments
  67. 8.12 Clario
  68. 8.12.1 Clario Company Information
  69. 8.12.2 Clario Business Overview
  70. 8.12.3 Clario Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Clario Decentralized Clinical Trial Software Product Portfolio
  72. 8.12.5 Clario Recent Developments
  73. 8.13 Castor
  74. 8.13.1 Castor Company Information
  75. 8.13.2 Castor Business Overview
  76. 8.13.3 Castor Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Castor Decentralized Clinical Trial Software Product Portfolio
  78. 8.13.5 Castor Recent Developments
  79. 8.14 Curebase
  80. 8.14.1 Curebase Company Information
  81. 8.14.2 Curebase Business Overview
  82. 8.14.3 Curebase Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Curebase Decentralized Clinical Trial Software Product Portfolio
  84. 8.14.5 Curebase Recent Developments
  85. 8.15 Infiuss
  86. 8.15.1 Infiuss Company Information
  87. 8.15.2 Infiuss Business Overview
  88. 8.15.3 Infiuss Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Infiuss Decentralized Clinical Trial Software Product Portfolio
  90. 8.15.5 Infiuss Recent Developments
  91. 8.16 AGILE
  92. 8.16.1 AGILE Company Information
  93. 8.16.2 AGILE Business Overview
  94. 8.16.3 AGILE Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  95. 8.16.4 AGILE Decentralized Clinical Trial Software Product Portfolio
  96. 8.16.5 AGILE Recent Developments
  97. 8.17 OpenClinica
  98. 8.17.1 OpenClinica Company Information
  99. 8.17.2 OpenClinica Business Overview
  100. 8.17.3 OpenClinica Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  101. 8.17.4 OpenClinica Decentralized Clinical Trial Software Product Portfolio
  102. 8.17.5 OpenClinica Recent Developments
  103. 8.18 ClinCapture
  104. 8.18.1 ClinCapture Company Information
  105. 8.18.2 ClinCapture Business Overview
  106. 8.18.3 ClinCapture Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  107. 8.18.4 ClinCapture Decentralized Clinical Trial Software Product Portfolio
  108. 8.18.5 ClinCapture Recent Developments
  109. 8.19 DFdiscover
  110. 8.19.1 DFdiscover Company Information
  111. 8.19.2 DFdiscover Business Overview
  112. 8.19.3 DFdiscover Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  113. 8.19.4 DFdiscover Decentralized Clinical Trial Software Product Portfolio
  114. 8.19.5 DFdiscover Recent Developments
  115. 8.20 ClinPlus CTMS
  116. 8.20.1 ClinPlus CTMS Company Information
  117. 8.20.2 ClinPlus CTMS Business Overview
  118. 8.20.3 ClinPlus CTMS Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  119. 8.20.4 ClinPlus CTMS Decentralized Clinical Trial Software Product Portfolio
  120. 8.20.5 ClinPlus CTMS Recent Developments
  121. 8.21 Dacima Clinical Suite
  122. 8.21.1 Dacima Clinical Suite Company Information
  123. 8.21.2 Dacima Clinical Suite Business Overview
  124. 8.21.3 Dacima Clinical Suite Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Dacima Clinical Suite Decentralized Clinical Trial Software Product Portfolio
  126. 8.21.5 Dacima Clinical Suite Recent Developments
  127. 8.22 Smartsheet
  128. 8.22.1 Smartsheet Company Information
  129. 8.22.2 Smartsheet Business Overview
  130. 8.22.3 Smartsheet Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Smartsheet Decentralized Clinical Trial Software Product Portfolio
  132. 8.22.5 Smartsheet Recent Developments
  133. 8.23 Snappii
  134. 8.23.1 Snappii Company Information
  135. 8.23.2 Snappii Business Overview
  136. 8.23.3 Snappii Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Snappii Decentralized Clinical Trial Software Product Portfolio
  138. 8.23.5 Snappii Recent Developments
  139. 8.24 RealTime-CTMS
  140. 8.24.1 RealTime-CTMS Company Information
  141. 8.24.2 RealTime-CTMS Business Overview
  142. 8.24.3 RealTime-CTMS Decentralized Clinical Trial Software Revenue and Gross Margin (2021-2026)
  143. 8.24.4 RealTime-CTMS Decentralized Clinical Trial Software Product Portfolio
  144. 8.24.5 RealTime-CTMS Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst